- Home
- BAFN vs NSPR Comparison
BAFN vs NSPR Comparison
Compare BAFN & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAFN
- NSPR
- Stock Information
- Founded
- BAFN 1999
- NSPR 2005
- Country
- BAFN United States
- NSPR United States
- Employees
- BAFN N/A
- NSPR N/A
- Industry
- BAFN Savings Institutions
- NSPR Medical/Dental Instruments
- Sector
- BAFN Finance
- NSPR Health Care
- Exchange
- BAFN Nasdaq
- NSPR Nasdaq
- Market Cap
- BAFN 70.2M
- NSPR 75.6M
- IPO Year
- BAFN N/A
- NSPR N/A
- Fundamental
- Price
- BAFN $16.61
- NSPR $2.61
- Analyst Decision
- BAFN
- NSPR Strong Buy
- Analyst Count
- BAFN 0
- NSPR 2
- Target Price
- BAFN N/A
- NSPR $4.75
- AVG Volume (30 Days)
- BAFN 10.6K
- NSPR 64.7K
- Earning Date
- BAFN 04-24-2025
- NSPR 05-13-2025
- Dividend Yield
- BAFN 1.90%
- NSPR N/A
- EPS Growth
- BAFN 134.19
- NSPR N/A
- EPS
- BAFN 2.62
- NSPR N/A
- Revenue
- BAFN $83,769,000.00
- NSPR $7,009,000.00
- Revenue This Year
- BAFN N/A
- NSPR $28.93
- Revenue Next Year
- BAFN N/A
- NSPR $172.18
- P/E Ratio
- BAFN $6.26
- NSPR N/A
- Revenue Growth
- BAFN 10.60
- NSPR 12.96
- 52 Week Low
- BAFN $10.40
- NSPR $1.81
- 52 Week High
- BAFN $19.75
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- BAFN 37.70
- NSPR 38.11
- Support Level
- BAFN $16.00
- NSPR $2.57
- Resistance Level
- BAFN $19.00
- NSPR $2.71
- Average True Range (ATR)
- BAFN 0.99
- NSPR 0.17
- MACD
- BAFN -0.34
- NSPR -0.02
- Stochastic Oscillator
- BAFN 16.27
- NSPR 24.00
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a one bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.